References
Bachmann CJ, Manthey T, Kamp-Becker I, Glaeske G, Hoffmann F (2013) Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany. Res Dev Disabil 34(9):2551–2563
Balkrishnan R, Phatak H, Gleim G, Karve S (2009) Assessment of the use of angiotensin receptor blockers in major European markets among paediatric population for treating essential hypertension. J Hum Hypertens 23(6):420–425
Chui CS, Man KK, Cheng CL, Chan EW, Lau WC, Cheng VC, Wong DS, Yang Kao YH, Wong IC (2014) An investigation of the potential association between retinal detachment and oral fluoroquinolones: a self-controlled case series study. J Antimicrob Chemother 15
Grinker RR, Yeargin-Allsopp M, Boyle C (2011) Culture and autism spectrum disorders: the impact on prevalence and recognition. In: Amaral D, Dawson G, Geschwind D (eds) Autism spectrum disorders. Oxford University Press, Oxford, pp 112–136
Hsia Y, Wong AY, Murphy DG, Simonoff E, Buitelaar JK, Wong IC (2014) Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study. Psychopharmacology (Berl) 231(6):999–1009
Livermore DM, Reynolds R, Stephens P, Duckworth G, Felmingham D, Johnson AP, Murchan S, Murphy O, Gungabissoon U, Waight P, Pebody R, Shackcloth J, Warner M, Williams L, George RC (2006) Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors. Int J Antimicrob Agents 28(4):273–279
Murray ML, Hsia Y, Glaser K, Simonoff E, Murphy DG, Asherson PJ, Eklund H, Wong IC (2014) Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care. Psychopharmacology (Berl) 231(6):1011–1021
Neubert A, Hsia Y, de Jong-van den Berg LT, Janhsen K, Glaeske G, Furu K, Kieler H, Nørgaard M, Clavenna A, Wong IC (2011) Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries. Br J Clin Pharmacol 72(6):969–977
Patel NC, CrismonML HK, Johnsrud MT, Rascati KL, Wilson JP (2006) Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program. Med Care 44(1):87–90
Rani F, Murray ML, Byrne PJ, Wong IC (2008) Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 121(5):1002–1009
Star K, Iessa N, Almandil NB, Wilton L, Curran S, Edwards IR, Wong IC (2012) Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis. J Child Adolesc Psychopharmacol 22(6):440–451
Sturkenboom MC, Verhamme KM, Nicolosi A, Murray ML, Neubert A, Caudri D, Picelli G, Sen EF, Giaquinto C, Cantarutti L, Baiardi P, Felisi MG, Ceci A, Wong IC, TEDDY European Network of Excellence (2008) Drug use in children: cohort study in three European countries. BMJ 24:337–a2245. doi:10.1136/bmj.a2245
Wong IC, Murray ML, Camilleri-Novak D, Stephens P (2004) Increased prescribing trends of pediatric psychotropic medications. Arch Dis Child 89(12):1131–1132
Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, Glaeske G, Valluri SC (2008) A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2(1):26. doi:10.1186/1753-2000-2-26
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wong, I.C.K., Hsia, Y. Authors’ response to Bachmann and Hoffman’s comments on psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study. Psychopharmacology 232, 985–988 (2015). https://doi.org/10.1007/s00213-014-3859-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-014-3859-9